...also conducted a direct public offering at $3.75 a share. SCO Capital and another investor, Elliot Associates...

...a major shareholder issued an open letter to the board in protest of the deal. Elliot Associates...
...of $5.25 the last trading day before the deal was announced (see BioCentury, June 4). Elliot Associates...
...in a registered direct offering of 8 million shares at $3.75. After the merger announcement, Elliot Associates...

...Aggrastat tirofiban to Manchester Securities for $25 million up front. Manchester is an affiliate of Elliot Associates...

...a percentage of its current and potential future commercial revenues to Manchester, a subsidiary of Elliot Associates...

...percentage of its current and potential future commercial revenues to Manchester Securities, an affiliate of Elliot Associates...

...million shares at $3.25. Investors included Alexandra Investment Management; Lurie Investments; Albert Fried & Co.; Elliot Associates...